Grau Lawson

By employing multiple linear regression, we investigated the associations between sociodemographic factors and motivation to reduce dementia risk (MCLHB-DRR scales), and between sociodemographic factors and motivation to reduce dementia risk in conjunction with health and lifestyle-based dementia risk (LIBRA index).

A total of 857 older adults,…[Read more]

Featuring remarkable antioxidant, anti-inflammatory, antimicrobial, and other pharmacological activities, it is a potent antioxidant. From 2019 to 2022, this review spotlights the progress in utilizing taxifolin to treat various diseases, analyzing its effects across the human body’s systems, including the nervous, immune, and digestive systems.…[Read more]

Romosozumab and weekly teriparatide were the subjects of new investigations or analyses, as part of pharmaceutical treatment research. Current and past intervention studies frequently involved vertebroplasty or kyphoplasty, often combined with stem cell or pharmaceutical approaches.

In patients suffering from endocrine diseases, the probability…[Read more]

The study found that Orientin curtails chondrocyte inflammation and ECM deterioration, hallmarks of osteoarthritis advancement. The effects of Orientin are mediated by the interconnected Nrf2/NF-κB and SIRT6/NF-κB signaling pathways. These results suggest that Orientin could prove to be a practical treatment option for osteoarthritis. This a…[Read more]